Some chemotherapeutic agents can "recall" the irradiated volumes by skin or pulmonary reactions in
cancer patients who previously received
radiation therapy. We report a recall
colitis following the administration of
paclitaxel-containing regimen in a patient who had been irradiated for a
carcinoma of the uterine cervix. A 63-year-old woman underwent a Wertheim operation because of uterine cervix
carcinoma. After 8 years of follow-up, a local recurrence was observed and she received curative external
radiotherapy (45 Gy) to the pelvis. No significant adverse events were observed during the
radiotherapy. Approximately one year later, she was hospitalized because of metastatic disease with
multiple pulmonary nodules, and a
chemotherapy regimen consisting of
paclitaxel and
carboplatin was administered. The day after the administration of
chemotherapy the patient had
diarrhea and rectal
bleeding. Histological examination of the biopsy taken from rectal hyperemic lesions showed a radiation
colitis. The symptoms reappeared after the administration of each course of
chemotherapy and continued until the death of the patient despite the interruption of the
chemotherapy. In conclusion, the probability of recall phenomena should be kept in mind in patients who received previously with pelvic
radiotherapy and treated later with cytotoxic
chemotherapy.